As SHCBP1 is repeatedly recognized as a key component in multi-gene prognostic models in several studies, its expression may function as a reliable biomarker for differentiating breast cancer patient risk and informing personalized treatment plans. Here, SHCBP1 is linked to breast carcinoma.